Preventive measures are crucial for at-risk pediatric populations. Prophylactic administration of TMP-SMX is recommended for:
HIV-infected children with low CD4 counts Children undergoing chemotherapy Organ transplant recipients
Additionally, maintaining good hygiene and avoiding exposure to environments where Pneumocystis might thrive (e.g., healthcare settings, areas with poor air quality) are essential preventive strategies.
